GSK just announced they are in licensing the siRNA compound from JNJ. They plan to study it sequentially with their ASO Bepi https://www.gsk.com/en-gb/media/press-releases/gsk-enters-agreement-to-obtain-exclusive-license-for-jnj-3989/